LONGMONT, COLO. (Nov. 18, 2021) — Proximo Medical, LLC, a business acceleration solution that addresses medical device commercialization challenges among startup and established medical device technologies looking to expand adoption in the U.S., today announced a partnership with Acarix, a Swedish medical device company that provides innovative solutions for rapid AI-based rule out of Coronary Artery Disease (CAD).
CASTLE PINES, COLO. (June 16, 2020) Today Proximo Medical, LLC, a business acceleration solution that addresses medical device commercialization challenges among startup and established medical device technologies looking to expand adoption in the U.S., announced a partnership with Coala Life, a leading Swedish-headquartered digital health company, in select U.S. markets.
CASTLE PINES, COLO. (May 12, 2020) Today Proximo Medical, LLC, a business acceleration solution that addresses medical device commercialization challenges among startup and established medical device technologies looking to expand adoption in the U.S., announced a partnership with EnviroTech Water Treatment, a leading manufacturer and supplier of antiseptic hand sanitizers Read more
CASTLE PINES, COLO. (April 16, 2020) Today Proximo Medical, LLC, a business acceleration solution that addresses medical device commercialization challenges among startup and established medical device technologies looking to expand adoption in the U.S., announced a partnership with Elucid Bioimaging, a developer of diagnostic image analysis software used to assist in the detection and treatment of heart attack and stroke. Read more
CASTLE PINES, COLO. Today Proximo Medical, LLC, a fractional commercial organization for start-up medical device technologies and established medical device companies looking to expand adoption in the U.S., announced a partnership in select U.S. markets with CeloNova Biosciences, Inc., a global medical device company that offers innovative products based upon its proprietary Polyzene™-F NanoCoating technology such as the novel COBRA PzF NanoCoated Coronary Stent (NCS). Read more
Novel technology designed to provide real-time perfusion monitoring
CASTLE PINES, Colo. — Proximo Medical, LLC today announced a partnership with PEDRA™ Technology, a Singapore based medical device innovator focused on the treatment of peripheral artery disease (PAD), for marketing and commercialization of its perfusion monitoring technology. Read more
CASTLE PINES, COLO. Proximo Medical, LLC today announced that it is the commercial partner for BIOTRONIK, Inc.’s peripheral vascular intervention (PVI) platform in select United States markets. BIOTRONIK, a global medical technology company headquartered in Berlin, Germany with U.S. offices in New York City and Lake Oswego, Oregon, develops trusted and innovative cardiovascular and endovascular solutions. Read more
Business acceleration solution to commercialize syringe technology for angiography
Proximo Medical today announced it has been selected by PMT Partners, a medical device innovator focused on the advancement of angiographic injectors, for commercialization of the PowrSyringe and AirTight Control Syringe technologies. Read more
Novel approach to start-up medical device commercialization capturing attention of innovators, investors.
Proximo Medical today announced that it has been selected as the marketing and commercial partner for Walk Vascular, an innovative medical device company that has developed JETi, a novel Peripheral Thrombectomy Catheter. Read more
Extends Proximo Medical’s leadership in marketing and commercialization solutions for medical device innovators
Proximo Medical today announced that it has been selected as the marketing and commercialization partner of choice for EMBA Medical™ Limited, a medical device company that designs and develops peripheral embolization technologies focused on improving safety, control, and outcomes. Read more